Cannabidiol: all 299 studies that test it

Page 2 of 3. Open to participants first (80), then studies with results posted, then the rest; newest registration first within each.

• Is Topical CBD Effective in Treating Thumb Joint ArthritisCompletedNCT04611347Phase 2Results posted
• Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled SeizuresTerminatedNCT04485104Phase 3Results posted
• RCT of CBD for Anxiety in Advanced Breast CancerActive, not recruitingNCT04482244Phase 2Results posted
• Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber SyndromeCompletedNCT04447846Phase 2Results posted
• Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate CancerCompletedNCT04428203Phase 1Results posted
• Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic TreatmentTerminatedNCT04421456Phase 2Results posted
• A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney StonesCompletedNCT04387617Phase 2/3Results posted
• A Clinical Trial of a Hemp-Derived Cannabidiol Product for AnxietyTerminatedNCT04286594Phase 2Results posted
• A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett SyndromeTerminatedNCT04252586Phase 3Results posted
• Oral Cannabidiol for Opioid WithdrawalCompletedNCT04238754Phase 1/2Results posted
• Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on BuprenorphineCompletedNCT04192370Phase 2Results posted
• Efficacy and Safety of Cannabidiol for Gastroparesis and Functional DyspepsiaCompletedNCT03941288Phase 2Results posted
• Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back PainTerminatedNCT03891264Phase 4Results posted
• Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett SyndromeTerminatedNCT03848832Phase 3Results posted
• Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic DermatitisCompletedNCT03824405Phase 2Results posted
• Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use DisorderCompletedNCT03787628Phase 2Results posted
• A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's DiseaseCompletedNCT03582137Phase 2Results posted
• Evaluation of BTX 1503 in Patients With Moderate to Severe Acne VulgarisCompletedNCT03573518Phase 2Results posted
• A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi SyndromeTerminatedNCT03458416Phase 2Results posted
• A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile SpasmsTerminatedNCT03421496Phase 3Results posted
• Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresTerminatedNCT03355300Phase 2Results posted
• Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresTerminatedNCT03336242Phase 2Results posted
• Cannabidiol as a Treatment for AUD Comorbid With PTSDCompletedNCT03248167Phase 1/2Results posted
• Cannabidiol Pharmacotherapy for Adults With Cannabis Use DisorderCompletedNCT03102918Phase 1Results posted
• Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)CompletedNCT02954887Phase 3Results posted
• Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)CompletedNCT02953548Phase 3Results posted
• Cannabidiol and Emotional StimuliCompletedNCT02902081Not applicableResults posted
• 4-drug Nerve Block Versus Plain Local Anesthetic for Knee and Hip Arthroplasty Analgesia in VeteransCompletedNCT02891798Phase 3Results posted
• Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi SyndromeTerminatedNCT02844933Phase 2Results posted
• A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's DiseaseCompletedNCT02818777Phase 2Results posted
• The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe EpilepsyTerminatedNCT02815540Phase 1/2Results posted
• Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSDCompletedNCT02759185Phase 2Results posted
• Characterization of the Analgesic Effect of CBD in Healthy, Normal VolunteersCompletedNCT02751359Phase 1/2Results posted
• University of Alabama at Birmingham (UAB) Adult CBD ProgramCompletedNCT02700412Phase 1Results posted
• University of Alabama at Birmingham (UAB) Pediatric CBD ProgramCompletedNCT02695537Phase 1Results posted
• A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedNCT02565108Phase 2Results posted
• An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedNCT02564952Phase 2Results posted
• Cannabidiol Oral Solution for Treatment of Refractory Infantile SpasmsTerminatedNCT02551731Phase 2Results posted
• A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)CompletedNCT02544763Phase 3Results posted
• An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)CompletedNCT02544750Phase 3Results posted
• Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent HumansCompletedNCT02539823Phase 2Results posted
• Cannabidiol Treatment in Patients With Early PsychosisCompletedNCT02504151Phase 2Results posted
• Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber SyndromeCompletedNCT02332655Phase 1/2Results posted
• Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure DisordersCompletedNCT02324673Phase 1/2Results posted
• Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure DisorderCompletedNCT02318602Phase 3Results posted
• GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet SyndromeCompletedNCT02224703Phase 3Results posted
• A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and AdultsCompletedNCT02224690Phase 3Results posted
• An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut SyndromesCompletedNCT02224573Phase 3Results posted
• Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and AdultsCompletedNCT02224560Phase 3Results posted
• Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)CompletedNCT02091375Phase 3Results posted
• A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)CompletedNCT02091206Phase 2Results posted
• A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic DisorderCompletedNCT02006628Phase 2Results posted
• Laboratory Study of Cannabidiol on the Effects of Smoked MarijuanaCompletedNCT01844687Phase 2Results posted
• Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent HumansCompletedNCT01605539Phase 2Results posted
• A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)CompletedNCT01562314Phase 2Results posted
• Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver DiseaseCompletedNCT01284634Phase 2Results posted
• GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II DiabetesCompletedNCT01217112Phase 2Results posted
• Cannabidiol Treatment of Cognitive Dysfunction in SchizophreniaCompletedNCT00588731Phase 2Results posted
• The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple SclerosisCompletedNCT07840924Phase 2
• Full-Spectrum Cannabidiol Oil for Anxiety and Depressive Symptoms in Parkinson's DiseaseCompletedNCT07651930Phase 2
• Safety and Pharmacokinetics of Cannabidiol in Healthy VolunteersCompletedNCT06854783Phase 1
• A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted ConditionsCompletedNCT06578455Phase 1
• High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast CancerSuspendedNCT06538389Phase 2
• Evaluating the Impact of a Novel Cannabinoid Product for EndometriosisActive, not recruitingNCT06477406Phase 2
• Effects of CBD on 2 Mile Run Time Trial PerformanceStatus unknownNCT06364254Not applicable
• Study of Cannabidiol (CBD) in Healthy VolunteersCompletedNCT06286839Not applicable
• CBD Knee Scope StudyWithdrawnNCT05934500Early Phase 1
• A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis ComplexCompletedNCT05864846Phase 4
• Evaluating Efficacy and Safety of CBD TPM Capsules for Use in InsomniaActive, not recruitingNCT05840822Phase 3
• A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep QualityCompletedNCT05839964Phase 1/2
• Cannabidiol to Reduce Anxiety ReactivityCompletedNCT05823753Phase 2
• Cannabidiol in Children and Young Adults With Rare Disease-associated Severe EpilepsyActive, not recruitingNCT05803434Phase 2
• Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEAStatus unknownNCT05766969Phase 1/2
• The Effects of CBD Isolate on Menstrual-Related SymptomsCompletedNCT05679830Phase 2
• Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer SurvivorsWithdrawnNCT05672342Early Phase 1
• Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis BullosaCompletedNCT05651607Phase 2
• Effect of Local Cannabidiol on Clinical and Inflammatory Outcomes in Periodontal Maintenance Patients.WithdrawnNCT05646459Phase 1
• Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled TrialCompletedNCT05632627Phase 2
• Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCICompletedNCT05630235Phase 1/2
• Cannabidiol (CBD) for the Treatment of Social Anxiety DisorderCompletedNCT05600114Phase 2
• Cannabidiol as a Treatment for Social Anxiety Disorder (R61)CompletedNCT05571592Phase 2
• Topical Cannabidiol Application and Skin Vascular ReactivityWithdrawnNCT05456113Not applicable
• Effectiveness of Cannabinoids on Appetite in SclerodermaCompletedNCT05416697Phase 3
• The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol DependenceStatus unknownNCT05387148Phase 2
• Improving Pain Disability With the Use of Oral CannabinoidsCompletedNCT05351905Not applicable
• Oral Cannabidiol Effect on Blood Pressure in Hypertensive PatientsCompletedNCT05346562Phase 1
• Epidiolex® for Anxiety in Pediatric EpilepsyCompletedNCT05324449Phase 4
• Safety of Co-Administered CHI-554 and AlcoholCompletedNCT05317507Phase 1
• CBD in Postmenopausal Women With OsteopeniaTerminatedNCT05317013Phase 1
• Reducing Pain and Opioid Use With CBDCompletedNCT05299944Phase 2
• CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann)Status unknownNCT05283161Phase 2/3
• Investigation of the Pharmacokinetic Profile of CBDCompletedNCT05269706Phase 1
• The CANabidiol Use for RElief of Short Term InsomniaCompletedNCT05253417Phase 2
• Effectiveness of Cannabidiol vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic SurgeryCompletedNCT05240755Early Phase 1
• Cannabidiol Effects on Cardiovascular System and Exercise ResponsesWithdrawnNCT05232123Early Phase 1
• Topical CBD for Musculoskeletal PainWithdrawnNCT05170451Phase 2/3
• CBD for Sleep in People With HIVWithdrawnNCT05097651Phase 2
• Cannabidiol for Reduction of Brain NeuroinflammationCompletedNCT05066308Phase 2
• The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-ACompletedNCT05049733Phase 1
• Topical Cannabidiol Cream and Post-exercise RecoveryWithdrawnNCT05044936Early Phase 1

← Cannabidiol overview